oral glp-1 medications fda approved The obesity treatment revolution is about to take its most consequential step yet. Eli Lilly's candidate orforglipron is on track for approval this month — positioning it as one Eli Lilly Gets Speedy FDA

First-line medications in the UK include: Methylphenidate (e.g., Concerta XL, Equasym XL, Medikinet XL)a stimulant that increases dopamine and noradrenaline availability Lisdexamfetamine (Elvanse)a prodrug stimulant for ADHD when significant impairment persists [19] [18] Atomoxetine (Strattera)a non-stimulant noradrenaline reuptake inhibitor, suitable when stimulants are contraindicated or ineffective Guanfacine (Intuniv)a non-stimulant alpha-2 adrenergic agonist licensed for children and adolescents aged 6-17 years Medication choice depends on individual factors including comorbidities (such as anxiety, tics, or substance misuse history), cardiovascular health, and patient preference

Dosing and label literacy: how to read a protocol or COA Reconstitution math example for hexarelin at 2 mg/vial: Add 2 mL bacteriostatic water to yield a concentration of 1 mg/mL (1000 mcg/mL)

Clinical Guidance and Prescriber Conversations Most pharmaceutical labeling notes breastfeeding as a caution category rather than a contraindication, meaning the decision requires individualized discussion between mother and healthcare team

Right off the bat, its startling how little information is available about BPC-157

Semaglutide and cardiovascular outcomes by baseline HbA1c and change in HbA1c in people with overweight or obesity but without diabetes in SELECT

Hundreds of millions of people worldwide still need help